MU
28
-3
CA
22
-3
DIS
85
3
BA
47
2
SLG
57
-3
IR
63
-3
SYF
86
-6
TSCO
44
-4
FRT
41
-2
CMA
61
-3
A
37
-2
PGR
59
-3
TJX
62
-2
OMC
50
-16
GOOGL
48
-5
AA
56
15
ISRG
71
-5
R
70
-3
EXC
54
3
HBI
58
3
MU
28
-3
CA
22
-3
DIS
85
3
BA
47
2
SLG
57
-3
IR
63
-3
SYF
86
-6
TSCO
44
-4
FRT
41
-2
CMA
61
-3
A
37
-2
PGR
59
-3
TJX
62
-2
OMC
50
-16
GOOGL
48
-5
AA
56
15
ISRG
71
-5
R
70
-3
EXC
54
3
HBI
58
3
Financhill
Back

ProPhase Labs Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
19

PRPH
ProPhase Labs

Last Price:
0.74
Seasonality Move:
14.29%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
19
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $0.75. The Score for PRPH is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $0.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 16.44 Sell
Chaikin Money Flow: 50708 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.22 - 2.56) Sell
Bollinger Bands (100): (1.91 - 3.27) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.99 Sell
20-day SMA: 1.77 Sell
50-day SMA: 2.17 Sell
200-day SMA: 3.91 Sell
8-day EMA: 1.03 Sell
20-day EMA: 1.54 Sell
50-day EMA: 2.07 Sell
200-day EMA: 3.52 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):